Peptides Targeting GDNF Family Receptor Alpha 1 (GFRα1) Mimic Glial Cell Line-Derived Neurotrophic Factor (GDNF)...

Area of Science:

• Neuroscience
• Biochemistry
• Regenerative Medicine

Background:

• Glial cell line-derived neurotrophic factor (GDNF) is a neuroprotective agent with therapeutic potential in regenerative medicine.
• Clinical applications of GDNF are hindered by challenges in its translation and delivery.
• Peptide mimetics offer a promising strategy to overcome GDNF's limitations.

Purpose of the Study:

• To identify and characterize novel peptide mimetics targeting the GDNF receptor GFRα1.
• To evaluate the binding affinity and biological activity of these peptides.
• To assess their potential for mimicking GDNF's neuroprotective and regenerative effects.

Main Methods:

• Screening of a 12-mer linear peptide phage display library against GFRα1.
• Computational alanine scanning mutagenesis to identify key binding residues.
• Synthesis and characterization of four hit peptides, including GFRα1 binding assays.
• Assessment of downstream signaling (PI3K pathway) and cellular proliferation in SH-SY5Y cells.
• Evaluation of neurite outgrowth in primary dorsal root ganglion neurons.

Main Results:

• Identification of four potent GFRα1-targeting peptides.
• Demonstration of GFRα1 binding affinity for all synthesized peptides.
• Activation of the phosphatidylinositol 3 kinase pathway and increased cellular proliferation by the peptides.
• Two peptides replicated the neurite outgrowth effects of recombinant GDNF in primary neurons.

Conclusions:

• Novel monomeric peptides targeting GFRα1 have been successfully identified.
• These peptides effectively mimic the biological functions of GDNF, including pathway activation and neurite outgrowth.
• The developed peptides represent a promising therapeutic strategy for regenerative medicine applications.